共 50 条
- [21] Breast Cancer Patient-Reported Quality of Life Outcomes Following Radiation Therapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E54 - E54
- [22] Stereotactic Body Radiation Therapy for Ultra-Large (> 100 cc) Prostate Glands: Oncologic, Toxicity and Patient-Reported Outcomes [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E276 - E276
- [24] Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer [J]. Radiation Oncology, 10
- [25] Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer [J]. RADIATION ONCOLOGY, 2015, 10
- [26] Patient-Reported Financial Toxicity Following Definitive Radiation Therapy for Localized Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E274 - E274
- [28] Dosimetric Correlates and Patient-Reported Quality of Life Among Prostate Cancer Patients Treated with Stereotactic Body Radiation Therapy (SBRT) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E120 - E120
- [29] Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E242 - E242
- [30] Dysuria following stereotactic body radiation therapy for prostate cancer [J]. FRONTIERS IN ONCOLOGY, 2015, 5